INTEGRA LIFESCIENCES HOLDING (IART) Stock News
NASDAQ:IART - Nasdaq - US4579852082 - Common Stock - Currency: USD
IART Latest News, Press Relases and Analysis
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology...
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and worst performers in the surgical equipment & consumables - specialty industry.
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in Q4, starting with Teleflex (NYSE:TFX).
Integra (IART) Down 7.5% Since Last Earnings Report: Can It Rebound?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Reasons IART is Risky and 1 Stock to Buy Instead
While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Integra LifeSciences has surged ahead as its stock price has climbed by 31.6% to $22.79 per share. This performance may have investors wondering how to approach the situation.
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology...
Why Is Integra LifeSciences (IART) Stock Rocketing Higher Today
Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 13.6% in the afternoon session after the company reported strong fourth quarter 2024 results that beat analysts' EPS and EBITDA expectations.
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the...
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025
PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...
Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)
New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge...
Meet the Only 3 S&P 500 Stocks That Are Beating Nvidia This Year
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior...